These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23092710)

  • 1. [Perinatality in the context of addictions].
    Courty P; Nacache L
    Presse Med; 2012 Dec; 41(12 Pt 1):1241-7. PubMed ID: 23092710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
    Debelak K; Morrone WR; O'Grady KE; Jones HE
    Am J Addict; 2013; 22(3):252-4. PubMed ID: 23617867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal Abstinence Syndrome: Presentation and Treatment Considerations.
    Jones HE; Kaltenbach K; Johnson E; Seashore C; Freeman E; Malloy E
    J Addict Med; 2016; 10(4):224-8. PubMed ID: 27244045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
    O'Connor AB; Collett A; Alto WA; O'Brien LM
    J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal Opioid Treatment: Human Experimental Research (MOTHER) Study: maternal, fetal and neonatal outcomes from secondary analyses.
    Bandstra ES
    Addiction; 2012 Nov; 107 Suppl 1():1-4. PubMed ID: 23106922
    [No Abstract]   [Full Text] [Related]  

  • 7. Gender and NAS: does sex matter?
    Holbrook A; Kaltenbach K
    Drug Alcohol Depend; 2010 Nov; 112(1-2):156-9. PubMed ID: 20576365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL; Rayburn WF
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multidisciplinary Approach to the Treatment of Co-occurring Opioid Use Disorder and Posttraumatic Stress Disorder in Pregnancy: A Case Report.
    Goodman DJ; Milliken CU; Theiler RN; Nordstrom BR; Akerman SC
    J Dual Diagn; 2015; 11(3-4):248-57. PubMed ID: 26457976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care.
    Pryor JR; Maalouf FI; Krans EE; Schumacher RE; Cooper WO; Patrick SW
    Arch Dis Child Fetal Neonatal Ed; 2017 Mar; 102(2):F183-F187. PubMed ID: 28073819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Perinatal Opioid Use Disorder.
    Boyars L; Guille C
    Obstet Gynecol Clin North Am; 2018 Sep; 45(3):511-524. PubMed ID: 30092925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observational study of buprenorphine treatment of opioid-dependent pregnant women in a family medicine residency: reports on maternal and infant outcomes.
    O'Connor A; Alto W; Musgrave K; Gibbons D; Llanto L; Holden S; Karnes J
    J Am Board Fam Med; 2011; 24(2):194-201. PubMed ID: 21383220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are there gender related differences in neonatal abstinence syndrome following exposure to buprenorphine during pregnancy?
    O'Connor AB; O'Brien L; Alto WA
    J Perinat Med; 2013 Sep; 41(5):621-3. PubMed ID: 23612625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal abstinence syndrome.
    Jansson LM; Velez M
    Curr Opin Pediatr; 2012 Apr; 24(2):252-8. PubMed ID: 22227786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women?
    Stitzer ML
    Addiction; 2013 Feb; 108(2):249-50. PubMed ID: 23331877
    [No Abstract]   [Full Text] [Related]  

  • 16. Pregnancy and the Opioid Epidemic.
    Haycraft AL
    J Psychosoc Nurs Ment Health Serv; 2018 Mar; 56(3):19-23. PubMed ID: 29505087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breastfeeding promotion for management of neonatal abstinence syndrome.
    Pritham UA
    J Obstet Gynecol Neonatal Nurs; 2013; 42(5):517-26. PubMed ID: 24020477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Maternal-Infant Interaction During Treatment for Opioid Withdrawal.
    Maguire DJ; Taylor S; Armstrong K; Shaffer-Hudkins E; DeBate R; Germain AM; Brooks SS
    Neonatal Netw; 2016; 35(5):297-304. PubMed ID: 27636694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of opioid dependence in the setting of pregnancy.
    Young JL; Martin PR
    Psychiatr Clin North Am; 2012 Jun; 35(2):441-60. PubMed ID: 22640765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perinatal outcomes of Australian buprenorphine-exposed mothers and their newborn infants.
    Patel P; Abdel-Latif ME; Hazelton B; Wodak A; Chen J; Emsley F; Feller JM; Lui K; Oei JL
    J Paediatr Child Health; 2013 Sep; 49(9):746-53. PubMed ID: 23745982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.